Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
44,286.07 +856.99 (+1.97%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Quest Diagnostics Incorporated (DGX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 135.22 |
| Open | 135.43 |
| Bid | 133.05 x 900 |
| Ask | 141.22 x 800 |
| Day's range | 135.19 - 136.24 |
| 52-week range | 119.59 - 158.34 |
| Volume | |
| Avg. volume | 912,315 |
| Market cap | 15.281B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 20.25 |
| EPS (TTM) | 6.71 |
| Earnings date | 31 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | 2.84 (2.09%) |
| Ex-dividend date | 16 Jan 2024 |
| 1y target est | 142.79 |
ZacksQuest Diagnostics (DGX) & CDC to Assess Hepatitis C Burden
Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.
ZacksDaVita HealthCare (DVA) Up 22.8% Since Last Earnings Report: Can It Continue?
DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR NewswireQuest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that it has been awarded a contract by the United States Centers for Disease Control and Prevention (CDC) designed to assess the burden of hepatitis C virus (HCV) in the United States
© 2023 Yahoo. All rights reserved.